Gogo Inc. (GOGO) Balances Military Wins With Market Challenges
Gogo Inc. (NASDAQ:GOGO) is one of the best high-return penny stocks to buy right now. On February 2, Gogo (NASDAQ:GOGO) confirmed its unit, SD Government SDG, has secured a T-1 certification from the US Air Force Air Mobility Command. The certification is for the company’s Roll-on/Roll-off Beyond Line of Sight communications capability for C-130 aircraft.
The certified Tactical Removable Airborne Satellite Communications (TRASC) system is designed to replace the existing C-130 forward escape hatch. Likewise, it can be installed in under 30 minutes, enabling rapid deployment of global broadband capability. The system is compatible with C-130 variants.
The certification paves the way for implementing the system in other military commands and with partner nations, thereby expanding the target market.
“This capability instantaneously brings all C-130 variants into the modern age of high-throughput Beyond-Line-of-Sight communications,” said Hayden Olson, Executive Vice President of SDG.
Meanwhile, on January 27, Moody’s Ratings downgraded Gogo’s rating to B2 from B1 due to competitive pressure in the jet connectivity market. The company is transitioning to a multi-orbit, multi-band connectivity provider following the acquisition of Satcom Direct.
Gogo Inc. (NASDAQ:GOGO) is a leading provider of broadband, in-flight connectivity, and wireless entertainment services for the business aviation market. It delivers high-speed internet, voice, and data services to private jets and corporate aircraft using a proprietary air-to-ground (ATG) network and satellite technologies.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window
The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.
After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"
Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.
Roadster is just an appetizer? Renowned investor predicts: SpaceX (SPCX.US) may announce the acquisition of Tesla (TSLA.US) within weeks at $420 per share
Gary Black, Managing Director of the Future Fund, recently tweeted a prediction that SpaceX may announce an all-stock acquisition of Tesla within weeks and view the launch of the flying edition Roadster as an opportunity to integrate Elon Musk's companies.
Crypto prices
More
